SAN ANTONIO, Jan. 17, 2017 -- Verify Markets’ analysis of the German Commercial Point of Use (POU) Water Treatment Market (http://www.verifymarkets.com/products/2017-commercial-point-of-use-water-treatment-market-germany) shows that the market was valued at over $50.0 million in 2016. The key market drivers include water hardness, a huge coffee market and a strong economy. Some of the challenges include clean and highly regulated water quality and an established and a competitive market. The market is expected to show a steady growth throughout the forecast period.
Some of the key players in the market include BWT, Brita, Pentair and 3M. The market has several OEM manufactures that participate as well. Brita emerged as the key market player in 2016 followed by BWT in second place.
The key end-user group in 2016 was the coffee machine manufacturers. Ion exchange emerged as the leading technology in 2016.
The study provides an overview of the German Commercial POU Water Treatment Market. The base year for the research is 2016; forecasts are provided until 2023. The study captures market drivers, restraints, market share analysis, revenue forecasts, pricing trends and distribution trends. The key companies included in this research are Brita, BWT, 3M, and Pentair, among others. A copy of the German Commercial POU Water Treatment Market research report can be obtained at http://www.verifymarkets.com.
Contact: Haley Rico Phone: 210-595-9687 Email: [email protected]


Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



